Gemini initiated with a Buy at Rosenblatt

Rosenblatt initiated coverage of Gemini (GEMI) with a Buy rating and $30 price target The firm sees the company benefitting from favorable crypto market conditions and growing “rapidly” with 55% annual sales growth through 2027. The company also has “significant” new product launches and tailwinds from regulatory clarity, the analyst tells investors in a research note.